The hottest biotechnology company in the world set

2022-07-26
  • Detail

The world's largest biotechnology company settled in Singapore

Amgen, the world's largest biotechnology enterprise, recently invested US $200million to build a pharmaceutical factory in Singapore, which is the first pharmaceutical factory built by the company in Asia. The pharmaceutical factory is expected to be completed in 2015 and will be licensed to produce pharmaceuticals in 2016. It is reported that the new drug factory to be built in Singapore will first focus on the production of monoclonal antibody agents

Amgen, headquartered in California, is one of the Fortune 500 companies. The group's total revenue in 2011 reached US $15.6 billion, mainly researching and developing drugs for the treatment of cancer, kidney disease, ③, rheumatoid arthritis, bone disease and other severe diseases

according to the Chinese and Russian governments' attention and support, Singapore has actively developed biomedicine in recent years. In the past five years, The Economic Development Bureau under the government has subsidized more than 300 people "China has received training from top biological product companies. In the past 10 years, biomedicine has created a large number of employment opportunities for Singapore, employing more than 6000 employees, twice the number of employees 10 years ago. 80% of the employees are Singaporeans. At present, the output value created has reached S $25billion, more than five times the total value of drugs 10 years ago. With the entry of Amgen, Singapore will have eight world-class biological product production facilities The total value of fixed assets will reach 2pla, and SGD 400million will be degraded through the random breaking (hydrolysis) of ester bonds in the chain segment. In the next three to four years, Singapore's bio industry will create 700 to 1000 jobs

Copyright © 2011 JIN SHI